Halozyme Therapeutics Inc (HALO)

40.12 +0.89  +2.27% NASDAQ Dec 4, 20:00 USD
View Full Chart
Price Chart
View All HALO News

News

View All Events

Events

Date Type Description
02/24/2021 Earnings Halozyme Therapeutics Inc Fourth Quarter Earnings for 2020 Release
02/24/2021 16:30 EST Misc Halozyme Therapeutics Inc Fourth Quarter Earnings Conference Call for 2020
11/02/2020 Earnings Halozyme Therapeutics Inc Third Quarter Earnings Result for 2020
11/02/2020 16:30 EST Misc Halozyme Therapeutics Inc Third Quarter Earnings Conference Call for 2020
08/10/2020 16:30 EDT Misc Halozyme Therapeutics Inc Second Quarter Earnings Conference Call for 2020
08/10/2020 Earnings Halozyme Therapeutics Inc Second Quarter Earnings Result for 2020
05/11/2020 16:30 EDT Misc Halozyme Therapeutics Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Halozyme Therapeutics Inc First Quarter Earnings Result for 2020
04/30/2020 Misc Halozyme Therapeutics Inc Annual General Meeting for 2019
02/24/2020 16:30 EST Misc Halozyme Therapeutics Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.halozyme.com
  • Investor Relations URL: http://www.halozyme.com/investors/default.aspx
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 24, 2021
  • Last Earnings Release: Nov. 02, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Top Fund Holders

Symbol Name Weighting
ARTSX Artisan Small Cap Investor 3.92%
BBP Virtus LifeSci Biotech Products ETF 3.84%
IYSBX Ivy Small Cap Core B 2.68%
BUISX Buffalo Small Cap Institutional 2.00%
WBSRX William Blair Small Cap Growth R6 1.60%
JGLYX JPMorgan Small Cap Growth R4 1.26%
XBI SPDR® S&P Biotech ETF 1.16%
GSCOX Goldman Sachs Small Cap Gr Insghts C 0.78%
JHSC JHancock Multifactor Small Cap ETF 0.53%
IWO iShares Russell 2000 Growth ETF 0.46%
USVM VictoryShares USAA MSCI USA Sm Cp VM ETF 0.38%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.18%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.